XyloCor Therapeutics

0 followers


XyloCor Therapeutics is a development-stage, biotechnology company dedicated to developing first-in-class gene therapies for patients with unmet medical need in cardiovascular disease.

Industries

Headquarters

Stage

Employees

Links

Org chart

Albert Gianchetti
Chief Executive Officer

Albert Gianchetti

Collapse
Howard Dittrich
Chief Medical Officer
Alexander Gaidamaka
SVP of Technology, Manufacturing & Quality
Tracy Rarick
VP, Program Development
Dawn Byrnes
VP, Clinical Operations
Todd Rosengart
Co-Founder